NO20011162D0 - FremgangsmÕter og preparater for modulering av interaksjonen mellom APJ-reseptoren og HIV-viruset - Google Patents

FremgangsmÕter og preparater for modulering av interaksjonen mellom APJ-reseptoren og HIV-viruset

Info

Publication number
NO20011162D0
NO20011162D0 NO20011162A NO20011162A NO20011162D0 NO 20011162 D0 NO20011162 D0 NO 20011162D0 NO 20011162 A NO20011162 A NO 20011162A NO 20011162 A NO20011162 A NO 20011162A NO 20011162 D0 NO20011162 D0 NO 20011162D0
Authority
NO
Norway
Prior art keywords
modulating
preparations
interaction
methods
hiv virus
Prior art date
Application number
NO20011162A
Other languages
English (en)
Norwegian (no)
Other versions
NO20011162L (no
Inventor
Robert Doms
Daryl Faulds
Joseph E Hesselgesser
Richard Horuk
Branislava Mitrovic
Yiqing Zhou
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO20011162L publication Critical patent/NO20011162L/no
Publication of NO20011162D0 publication Critical patent/NO20011162D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7158—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for chemokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • AIDS & HIV (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO20011162A 1998-09-08 2001-03-07 FremgangsmÕter og preparater for modulering av interaksjonen mellom APJ-reseptoren og HIV-viruset NO20011162D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/149,045 US6475718B2 (en) 1998-09-08 1998-09-08 Methods and compositions for modulating the interaction between the APJ receptor and the HIV virus
PCT/EP1999/006553 WO2000014220A1 (en) 1998-09-08 1999-09-07 Methods and compositions for modulating the interaction between the apj receptor and the hiv virus

Publications (2)

Publication Number Publication Date
NO20011162L NO20011162L (no) 2001-03-07
NO20011162D0 true NO20011162D0 (no) 2001-03-07

Family

ID=22528559

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20011162A NO20011162D0 (no) 1998-09-08 2001-03-07 FremgangsmÕter og preparater for modulering av interaksjonen mellom APJ-reseptoren og HIV-viruset

Country Status (14)

Country Link
US (5) US6475718B2 (ru)
EP (1) EP1109906A1 (ru)
JP (1) JP2002532061A (ru)
KR (1) KR20020013467A (ru)
AU (1) AU767484B2 (ru)
BR (1) BR9913635A (ru)
CA (1) CA2341782A1 (ru)
HU (1) HUP0103768A3 (ru)
IL (1) IL141452A0 (ru)
NO (1) NO20011162D0 (ru)
PL (1) PL346564A1 (ru)
RU (1) RU2225721C2 (ru)
SK (1) SK3082001A3 (ru)
WO (1) WO2000014220A1 (ru)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2403447A1 (en) * 2000-03-23 2001-09-27 Takeda Chemical Industries, Ltd. Peptide derivative
AU2001264937A1 (en) * 2000-05-23 2001-12-03 Genaissance Pharmaceuticals, Inc. Haplotypes of the agtrl1 gene
WO2006023893A2 (en) * 2004-08-23 2006-03-02 Arizona Board Of Regents On Behalf Of The University Of Arizona Methods for modulating angiogenesis and apoptosis with apelin compositions
JP4954326B2 (ja) 2008-04-11 2012-06-13 中外製薬株式会社 複数分子の抗原に繰り返し結合する抗原結合分子
TWI440469B (zh) 2008-09-26 2014-06-11 Chugai Pharmaceutical Co Ltd Improved antibody molecules
EP4231014A3 (en) * 2010-11-30 2024-03-20 Chugai Seiyaku Kabushiki Kaisha Antigen-binding molecule capable of binding to plurality of antigen molecules repeatedly
US20140093496A1 (en) 2011-02-25 2014-04-03 Chugai Seiyaku Kabushiki Kaisha Fc-gamma-RIIb-SPECIFIC Fc ANTIBODY
CA2832109C (en) 2011-06-10 2021-07-06 Oregon Health & Science University Cmv glycoproteins and recombinant vectors
EP2762493B1 (en) 2011-09-30 2021-06-09 Chugai Seiyaku Kabushiki Kaisha Antigen-binding molecule promoting disappearance of antigens having plurality of biological activities
TW201326209A (zh) 2011-09-30 2013-07-01 Chugai Pharmaceutical Co Ltd 具有促進抗原清除之ＦｃＲｎ結合域的治療性抗原結合分子
CA2851397C (en) * 2011-12-16 2020-03-10 Cargill, Incorporated Environmentally-friendly improved deicer compositions
BR112015020587A2 (pt) 2013-03-14 2017-10-10 Regeneron Pharma proteínas de fusão de apelina e suas utilizações
AU2014352962B2 (en) 2013-11-20 2019-11-07 Regeneron Pharmaceuticals, Inc. APLNR modulators and uses thereof
EA201791366A1 (ru) 2014-12-19 2018-02-28 Чугаи Сейяку Кабусики Кайся Антитела к c5 и способы их применения
MY181199A (en) 2014-12-19 2020-12-21 Chugai Pharmaceutical Co Ltd Anti-myostatin antibodies, polypeptides containing variant fc regions, and methods of use
CN107108729A (zh) 2015-02-05 2017-08-29 中外制药株式会社 包含离子浓度依赖性的抗原结合结构域的抗体，fc区变体，il‑8‑结合抗体，及其应用
BR112017014067B1 (pt) 2015-02-27 2021-01-12 Chugai Seiyaku Kabushiki Kaisha usos de um anticorpo receptor de il-6 para no tratamento de doenças relacionadas a il-6
US11359009B2 (en) 2015-12-25 2022-06-14 Chugai Seiyaku Kabushiki Kaisha Anti-myostatin antibodies and methods of use
KR20230079499A (ko) 2016-08-05 2023-06-07 추가이 세이야쿠 가부시키가이샤 Il-8 관련 질환의 치료용 또는 예방용 조성물
JP7191833B2 (ja) 2017-01-30 2022-12-19 中外製薬株式会社 抗スクレロスチン抗体およびその使用
WO2018203545A1 (ja) 2017-05-02 2018-11-08 国立研究開発法人国立精神・神経医療研究センター Ｉｌ－６及び好中球の関連する疾患の治療効果の予測及び判定方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0975749A2 (en) 1996-05-28 2000-02-02 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Cc chemokine receptor 5, antibodies thereto, transgenic animals
US6528625B1 (en) * 1996-10-28 2003-03-04 Millennium Pharmaceuticals, Inc. Anti-CCR5 antibodies and kits comprising same

Also Published As

Publication number Publication date
IL141452A0 (en) 2002-03-10
EP1109906A1 (en) 2001-06-27
KR20020013467A (ko) 2002-02-20
NO20011162L (no) 2001-03-07
US6475718B2 (en) 2002-11-05
JP2002532061A (ja) 2002-10-02
US20030008391A1 (en) 2003-01-09
HUP0103768A2 (hu) 2002-02-28
AU5973799A (en) 2000-03-27
US20030008279A1 (en) 2003-01-09
AU767484B2 (en) 2003-11-13
SK3082001A3 (en) 2001-09-11
BR9913635A (pt) 2001-05-22
US20020062488A1 (en) 2002-05-23
PL346564A1 (en) 2002-02-11
RU2225721C2 (ru) 2004-03-20
CA2341782A1 (en) 2000-03-16
US20030003447A1 (en) 2003-01-02
WO2000014220A1 (en) 2000-03-16
US20030008376A1 (en) 2003-01-09
HUP0103768A3 (en) 2004-07-28

Similar Documents

Publication Publication Date Title
NO20011162D0 (no) FremgangsmÕter og preparater for modulering av interaksjonen mellom APJ-reseptoren og HIV-viruset
IS5953A (is) Lyfjablöndur úr örgerðum eplerenonum
NO20004104L (no) Preparater omfattende virus og fremgangsmater for konsentrering av viruspreparater
DK0866117T3 (da) Mikroemulsion
NO992736D0 (no) Ikke oppgitt
DK0921796T3 (da) Tetrahydrolipstatinholdige præparater
DE69630044D1 (de) Viren inaktivierende umhüllungen
EE03903B1 (et) Omeprasooli ravimvorm
NO965539D0 (no) Farmasöytiske tacrinepreparater
ID28258A (id) Metode dan aparatus untuk balok seimbang memperkuat sesitifitas
NO20003302D0 (no) Vaksine
TR199700343A3 (tr) Titresimli blender.
NO20020571D0 (no) Peptider som blokkerer virusinfeksjonsevnen og fremgangsmåter for anvendelse av disse
NO910381D0 (no) Fremgangsmaate ved sammenfoeyning av konstruksjonselementer.
DK1109450T3 (da) Mikrokapselpræparater
NO983472D0 (no) Taxoider, deres fremstilling og farmas°ytiske preparater inneholdende taxoidene
DE59813144D1 (de) Teilchenmanipulierung
NO20004349L (no) Metoder og anordninger for modulering av immunresponsen
ATE246494T1 (de) Brausezubereitungen
DE69906934D1 (de) Arzneizubereitungen
AU7471098A (en) Recombinant influenza viruses expressing tumor-associated antigens as antitum or agents
EE9900455A (et) Uus menetlus
FR2763497B1 (fr) Aspirateur tous usages
NL300165I2 (nl) Babesiavaccin.
DK1105498T3 (da) HIV vaccine

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application